Milestone Pharmaceuticals Inc. (MIST) Misses Q1 EPS by 43c

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q1 EPS of ($0.20), $0.43 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $238 thousand versus the consensus estimate of $56.34 million.

For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.

You May Also Be Interested In

• Freedom Broker Upgrades Satellogic, Inc. (SATL) to Buy, 'Growth quality is improving'
• Redwire Corporation (RDW) call put ratio 4.2 calls to 1 put with a focus on July 2 weekly calls
• Optimi Health ships psilocybin capsules to Australia in third export